A group of Senators has warned the FDA about an ad expected to air during Sunday’s big game that they believe misleads ...

Two senators wrote to the FDA Friday about the Hims Super Bowl ad, which they said misleads patients about compounded weight ...

Following the president’s recent executive order dismantling diversity, equity, and inclusion policies, the main page for the ...

Fang's op-ed article on RFK Jr. gave me a flicker of hope that maybe The Times will actually present some sophisticated views ...

Kennedy vowed to divest his financial interest in vaccine litigation to his son. Democrats and ethics experts said the ...

The Trump administration has put a freeze on many federal health agency communications with the public through at least the ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression ...

The US Food and Drug Administration has issued a warning letter to French drugmaker Sanofi (Euronext: SAN) following an inspection of its Massachusetts manufacturing site. The missive raises concerns ...

‘No legal basis’ to pause IRA cuts, say Warren, Sanders, Wyden Drug companies pushing to stop Biden’s Medicare ... betray your own campaign promises,” the lawmakers said. The letter follows ...

Despite receiving a prior wrist slap from the FDA in the shape of a Form 483, Sanofi is still working to right the ship at a U.S. drug ingredients plant tied to its longstanding subsidiary Genzyme.

Jan. 21, 2025 -- The FDA has approved a new treatment for patients with a common form of breast cancer that has spread to other parts of the body or cannot be surgically removed. The drug ...

Jan 21 (Reuters) - The U.S. Food and Drug Administration expanded approval for Johnson & Johnson's (JNJ.N), opens new tab nasal spray, Spravato, to allow it to be used as a standalone treatment ...